Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3EK2Il6
via IFTTT